In vitro blood-brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms.

In vitro blood-brain barrier (BBB) models are indispensable screening tools for obtaining early information about the brain-penetrating behaviour of promising drug candidates. Until now, in vitro BBB models have focused on investigating the interplay among cellular components of neurovascular units and the effect of fluidic sheer stress in sustaining normal BBB phenotype and functions. However, an area that has received less recognition is the role of the noncellular basement membrane (BM) in modulating BBB physiology. This review describes the state-of-the-art on in vitro BBB models relevant in drug discovery research and highlights their strengths, weaknesses and the utility potential of some of these models in testing the permeability of nanocarriers as vectors for delivering therapeutics to the brain. Importantly, our review also introduces a new concept of engineering artificial BM platforms for reconstituting BBB models in vitro.

[1]  R. Keep,et al.  Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier , 2008, Current neuropharmacology.

[2]  Y. Kanai,et al.  Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis , 2006, Laboratory Investigation.

[3]  Maxime Culot,et al.  A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells , 2014, PloS one.

[4]  H. Gutmann,et al.  Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood–brain barrier , 2005, Brain Research.

[5]  H. Wolburg,et al.  Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier , 2009, The Neuroscientist.

[6]  R. Liddington Mapping out the basement membrane , 2001, Nature Structural Biology.

[7]  A. Yu,et al.  Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.

[8]  A. Traweger,et al.  “You Shall Not Pass”—tight junctions of the blood brain barrier , 2014, Front. Neurosci..

[9]  A. D'emanuele,et al.  Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.

[10]  Dóra Hantosi,et al.  Blood-brain barrier co-culture models to study nanoparticle penetration: focus on co-culture systems , 2015 .

[11]  Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model , 2013, Alzheimer's Research & Therapy.

[12]  B. Långström,et al.  Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport , 2009, Drug Metabolism and Disposition.

[13]  Stanley E. Lazic,et al.  Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models , 2012, PloS one.

[14]  H. Galla,et al.  The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. , 2011, The international journal of biochemistry & cell biology.

[15]  V. Teichberg,et al.  Closing the gap between the in-vivo and in-vitro blood–brain barrier tightness , 2009, Brain Research.

[16]  Arne Fischmann,et al.  Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin , 2002, Acta Neuropathologica.

[17]  Marcus J. Drake,et al.  The Validation of a Functional, Isolated Pig Bladder Model for Physiological Experimentation , 2012, Front. Pharmacol..

[18]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[19]  S. Johansson,et al.  Assembly of Laminin Polymers Is Dependent on β1-Integrins , 2001 .

[20]  G. Bix,et al.  Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis? , 2012, Front. Pharmacol..

[21]  W. Hsieh,et al.  Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier , 2013, Journal of biomaterials applications.

[22]  C. Schwerk,et al.  Culture models to study leukocyte trafficking across the choroid plexus , 2013, Fluids and Barriers of the CNS.

[23]  Y. Kuo,et al.  Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles. , 2013, Biomaterials.

[24]  G. D. del Zoppo,et al.  Interendothelial Claudin-5 Expression Depends on Cerebral Endothelial Cell–Matrix Adhesion by β1-Integrins , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Emma East,et al.  A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis , 2009, Journal of tissue engineering and regenerative medicine.

[26]  Kelvin H. Lee,et al.  Membrane configuration optimization for a murine in vitro blood–brain barrier model , 2013, Journal of Neuroscience Methods.

[27]  Yu Cao,et al.  Cell-Culture Models of the Blood–Brain Barrier , 2014, Stroke.

[28]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  T. Terasaki,et al.  Exogenous expression of claudin‐5 induces barrier properties in cultured rat brain capillary endothelial cells , 2007, Journal of cellular physiology.

[30]  Hong Ding,et al.  MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrier , 2009, Brain Research.

[31]  M Gumbleton,et al.  Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. , 2001, Journal of pharmaceutical sciences.

[32]  Luca Cucullo,et al.  In vitro blood-brain barrier models: current and perspective technologies. , 2012, Journal of pharmaceutical sciences.

[33]  T. Kanda,et al.  Establishment and characterization of spinal cord microvascular endothelial cell lines , 2013 .

[34]  L. Rubin,et al.  A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.

[35]  S. Rapoport,et al.  Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride , 1986, Journal of neurochemistry.

[36]  Andreas Reichel,et al.  An overview of in vitro techniques for blood-brain barrier studies. , 2003, Methods in molecular medicine.

[37]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[38]  William Shain,et al.  An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. , 2005, Lab on a chip.

[39]  Edward J. Rapp,et al.  Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[41]  Yan Zhang,et al.  Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Z. Nagy,et al.  Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  K. Plate,et al.  Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.

[44]  Joachim Wegener,et al.  The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. , 2007, Experimental cell research.

[45]  M. Gumbleton,et al.  Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting , 2007, Journal of drug targeting.

[46]  S. Saxena,et al.  Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study , 2013, PloS one.

[47]  A. McMahon,et al.  Wnt family proteins are secreted and associated with the cell surface. , 1993, Molecular biology of the cell.

[48]  Edward J. Rapp,et al.  Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability study , 2006, Brain Research.

[49]  G. Grau,et al.  Platelets Potentiate Brain Endothelial Alterations Induced by Plasmodium falciparum , 2006, Infection and Immunity.

[50]  M. Corada,et al.  The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? , 2011, Pharmacological research.

[51]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[52]  Rongqin Huang,et al.  A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. , 2010, Biomaterials.

[53]  Calvin J Kuo,et al.  Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis , 2009, Proceedings of the National Academy of Sciences.

[54]  W. Haefeli,et al.  NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics , 2007, Cell and Tissue Research.

[55]  P. Couraud,et al.  Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation , 2012, Fluids and Barriers of the CNS.

[56]  Eric V Shusta,et al.  In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[57]  T. Tilling,et al.  Basement Membrane Proteins Influence Brain Capillary Endothelial Barrier Function In Vitro , 1998, Journal of neurochemistry.

[58]  Y. Kuo,et al.  Solid lipid nanoparticles carrying chemotherapeutic drug across the blood–brain barrier through insulin receptor-mediated pathway , 2013, Journal of drug targeting.

[59]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[60]  Michael L Shuler,et al.  Murine in vitro model of the blood-brain barrier for evaluating drug transport. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  L. Fenart,et al.  Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.

[62]  J. Brillault,et al.  Lessons from CADASIL , 2002, Annals of the New York Academy of Sciences.

[63]  P. Couraud,et al.  The hCMEC/D3 cell line as a model of the human blood brain barrier , 2013, Fluids and Barriers of the CNS.

[64]  P. Searson,et al.  Influence of Basement Membrane Proteins and Endothelial Cell-Derived Factors on the Morphology of Human Fetal-Derived Astrocytes in 2D , 2014, PloS one.

[65]  Luca Cucullo,et al.  Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic Drugs , 2007, Epilepsia.

[66]  S. Strickland,et al.  Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity , 2014, Nature Communications.

[67]  K. Hynynen,et al.  Noninvasive and targeted drug delivery to the brain using focused ultrasound. , 2013, ACS chemical neuroscience.

[68]  D. Stepensky,et al.  Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[69]  F. Smedts,et al.  Bioengineering of living renal membranes consisting of hierarchical, bioactive supramolecular meshes and human tubular cells. , 2011, Biomaterials.

[70]  F. Charron,et al.  The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.

[71]  M. Deli Blood-brain barrier models , 2007 .

[72]  T. Tsuruo,et al.  Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-β production , 2005, Brain Research.

[73]  Xin-guo Jiang,et al.  Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. , 2014, Acta biomaterialia.

[74]  J. Berwick,et al.  LRP-1-mediated intracellular antibody delivery to the Central Nervous System , 2015, Scientific Reports.

[75]  Á. Kittel,et al.  A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes , 2009, Neurochemistry International.

[76]  J. Toldi,et al.  Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid , 2012, Journal of Neural Transmission.

[77]  Kosuke Saito,et al.  Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: A promising tool for human blood–brain barrier studies , 2012, Brain Research.

[78]  W. Banks,et al.  From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.

[79]  U. Bickel,et al.  How to measure drug transport across the blood-brain barrier , 2011, NeuroRX.

[80]  K. M. Baeten,et al.  Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke , 2011, Developmental neurobiology.

[81]  T. Terasaki,et al.  A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.

[82]  Hong Yuan,et al.  Brain-targeting study of stearic acid–grafted chitosan micelle drug-delivery system , 2012, International journal of nanomedicine.

[83]  J. Hubbell,et al.  Molecularly Engineered Self‐Assembling Membranes for Cell‐Mediated Degradation , 2015, Advanced healthcare materials.

[84]  Oliver Distler,et al.  Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.

[85]  Y. Kuo,et al.  Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. , 2012, Colloids and surfaces. B, Biointerfaces.

[86]  V. Weaver,et al.  Extracellular matrix assembly: a multiscale deconstruction , 2014, Nature Reviews Molecular Cell Biology.

[87]  B. Engelhardt,et al.  The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.

[88]  C. Capobianco,et al.  An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis , 2007, Angiogenesis.

[89]  Maxime Culot,et al.  Modelling of the blood–brain barrier in drug discovery and development , 2007, Nature Reviews Drug Discovery.

[90]  A. Prat,et al.  Glial influence on the Blood Brain Barrier , 2013, Glia.

[91]  T. Nagai,et al.  Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Luca Cucullo,et al.  The role of shear stress in Blood-Brain Barrier endothelial physiology , 2011, BMC Neuroscience.

[93]  T. Kanda,et al.  Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood–brain barrier function , 2010, Journal of cellular physiology.

[94]  O. Ogunshola,et al.  Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia , 2014, British journal of pharmacology.

[95]  Rui L Reis,et al.  Self-assembly in nature: using the principles of nature to create complex nanobiomaterials. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[96]  L. Kaczmarek,et al.  Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier , 2014 .

[97]  P Delorme,et al.  An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.

[98]  J. Pachter,et al.  Where is the blood–brain barrier … really? , 2005, Journal of neuroscience research.

[99]  Peter C. Searson,et al.  The blood-brain barrier: an engineering perspective , 2013, Front. Neuroeng..

[100]  I. Wilhelm,et al.  In vitro models of the blood-brain barrier for the study of drug delivery to the brain. , 2014, Molecular pharmaceutics.

[101]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[102]  Sean P. Palecek,et al.  A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources , 2014, Scientific Reports.

[103]  M. Dehouck,et al.  Adapting coculture in vitro models of the blood–brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration , 2016, Laboratory Investigation.

[104]  N. Abbott Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation , 2005, Cellular and Molecular Neurobiology.

[105]  Xiaoyu Xu,et al.  A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat , 2013, International journal of biological sciences.

[106]  Te-Wei Lee,et al.  In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery , 2013, International journal of molecular sciences.

[107]  M. Masserini,et al.  Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[108]  Qiang Zhang,et al.  Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[109]  J M Scherrmann,et al.  Drug delivery to brain via the blood-brain barrier. , 2002, Vascular pharmacology.

[110]  Ignacio A. Romero,et al.  Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models , 2011, Journal of Neuroscience Methods.

[111]  N J Abbott,et al.  Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.

[112]  M. Dehouck,et al.  Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery. , 2016, Trends in biotechnology.

[113]  Kelvin H. Lee,et al.  Optimization of endothelial cell growth in a murine in vitro blood–brain barrier model , 2011, Biotechnology journal.

[114]  L. Fenart,et al.  Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier , 2004, Brain Research.

[115]  P Couvreur,et al.  Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties , 2005, Journal of neurochemistry.

[116]  H. von Briesen,et al.  Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model , 2010, PloS one.

[117]  R. Uzbekov,et al.  Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. , 2011, Current neurovascular research.

[118]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[119]  L. Fenart,et al.  Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier. , 2013, Current Alzheimer research.

[120]  P. Gaillard,et al.  Enhanced brain drug delivery: safely crossing the blood-brain barrier. , 2012, Drug discovery today. Technologies.

[121]  Yan Zhang,et al.  Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[122]  S. Liebner,et al.  In vitro models of the blood-brain barrier. , 2014, Methods in molecular biology.

[123]  N. Abbott,et al.  Astrocyte–endothelial interactions and blood–brain barrier permeability * , 2002 .

[124]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[125]  G. Bezakova,et al.  New insights into the roles of agrin , 2003, Nature Reviews Molecular Cell Biology.

[126]  M. Osanai,et al.  Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. , 2008, Molecular biology of the cell.

[127]  P. Couraud,et al.  Expression and localization of claudins-3 and -12 in transformed human brain endothelium , 2012, Fluids and Barriers of the CNS.

[128]  J. Hartgerink,et al.  Self-assembly of peptide-amphiphile nanofibers: the roles of hydrogen bonding and amphiphilic packing. , 2006, Journal of the American Chemical Society.

[129]  S. Krähenbühl,et al.  The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies , 2008, Journal of neurochemistry.

[130]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[131]  Yan Li,et al.  A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. , 2012, Biomaterials.

[132]  D. Bergles,et al.  Human astrocytes develop physiological morphology and remain quiescent in a novel 3D matrix. , 2015, Biomaterials.

[133]  Y. Kuo,et al.  Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier. , 2012, Colloids and surfaces. B, Biointerfaces.

[134]  A. Moses,et al.  Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies , 2013, Fluids and Barriers of the CNS.

[135]  N. Rothwell,et al.  An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood–brain barrier model , 2012, Brain Research.

[136]  P. Couraud,et al.  Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.

[137]  P. Couraud,et al.  ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected]. , 2010, Molecular pharmaceutics.

[138]  K. Hayashi,et al.  Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells , 2007, Cellular and Molecular Neurobiology.

[139]  C. Catania,et al.  Neurons and ECM regulate occludin localization in brain endothelial cells , 2000, Neuroreport.

[140]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[141]  B. Engelhardt,et al.  Endothelial Cell Laminin Isoforms, Laminins 8 and 10, Play Decisive Roles in T Cell Recruitment across the Blood–Brain Barrier in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of cell biology.

[142]  M. Mayberg,et al.  A new dynamic in vitro model for the multidimensional study of astrocyte–endothelial cell interactions at the blood–brain barrier , 2002, Brain Research.

[143]  Gilberto Alves,et al.  Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[144]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[145]  E. Hohenester,et al.  Laminins in basement membrane assembly , 2013, Cell adhesion & migration.

[146]  P. Couraud,et al.  Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes , 2014, PloS one.

[147]  J. Cryan,et al.  Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance , 2014, Pharmaceutical Research.

[148]  Maria Antfolk,et al.  In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches. , 2015, Journal of pharmaceutical sciences.

[149]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[150]  I. Sherman,et al.  Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. , 1996, International journal for parasitology.

[151]  Á. Kittel,et al.  Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[152]  Lihong Liu,et al.  Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.

[153]  Sean P. Palecek,et al.  Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.

[154]  D. Begley,et al.  Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles , 2003, Pharmaceutical Research.

[155]  F. Orsenigo,et al.  Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5 , 2008, Nature Cell Biology.